225 related articles for article (PubMed ID: 18467435)
1. Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats.
Schakman O; Kalista S; Bertrand L; Lause P; Verniers J; Ketelslegers JM; Thissen JP
Endocrinology; 2008 Aug; 149(8):3900-8. PubMed ID: 18467435
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of muscle atrophy induced by glucocorticoids.
Schakman O; Gilson H; Kalista S; Thissen JP
Horm Res; 2009 Nov; 72 Suppl 1():36-41. PubMed ID: 19940494
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
4. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.
Yin HN; Chai JK; Yu YM; Shen CA; Wu YQ; Yao YM; Liu H; Liang LM; Tompkins RG; Sheng ZY
J Trauma; 2009 Apr; 66(4):1083-90. PubMed ID: 19359918
[TBL] [Abstract][Full Text] [Related]
5. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
8. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
Singh LP; Jiang Y; Cheng DW
Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
[TBL] [Abstract][Full Text] [Related]
11. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of glucocorticoids and IGF-1 on myogenic differentiation through the Akt/GSK-3β pathway in C2C12 myoblasts.
Fang XB; Song ZB; Xie MS; Liu YM; Zhang WX
Int J Neurosci; 2020 Nov; 130(11):1125-1135. PubMed ID: 32070170
[No Abstract] [Full Text] [Related]
13. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
14. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
15. AKT/GSK-3beta/beta-catenin signalling within hippocampus and amygdala reflects genetically determined differences in posttraumatic stress disorder like symptoms.
Dahlhoff M; Siegmund A; Golub Y; Wolf E; Holsboer F; Wotjak CT
Neuroscience; 2010 Sep; 169(3):1216-26. PubMed ID: 20576499
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats.
Schakman O; Gilson H; de Coninck V; Lause P; Verniers J; Havaux X; Ketelslegers JM; Thissen JP
Endocrinology; 2005 Apr; 146(4):1789-97. PubMed ID: 15661854
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
18. Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.
Ishikawa S; Kuno A; Tanno M; Miki T; Kouzu H; Itoh T; Sato T; Sunaga D; Murase H; Miura T
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2536-44. PubMed ID: 22505645
[TBL] [Abstract][Full Text] [Related]
19. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus.
Orellana AM; Vasconcelos AR; Leite JA; de Sá Lima L; Andreotti DZ; Munhoz CD; Kawamoto EM; Scavone C
Aging (Albany NY); 2015 Dec; 7(12):1094-111. PubMed ID: 26647069
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of glucocorticoid-induced myopathy.
Schakman O; Gilson H; Thissen JP
J Endocrinol; 2008 Apr; 197(1):1-10. PubMed ID: 18372227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
